This technology utilizes three-dimensional spheroid culture techniques to transform human pericytes isolated from the aortic adventitia into pluripotent cells.
Researchers at the University of Pittsburgh and the University of Pennsylvania have identified Profilin1 (Pfn1) as a novel therapeutic target for atherosclerosis.